Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The International Society for Pharmaceutical Engineering Delaware Valley Chapter (ISPE DVC) announces the 31st Annual ISPE DVC Symposium & Exhibition on Tuesday, May 16, 2023, at Lincoln Financial Field.
read more
Wheeler Bio, Inc., a boutique contract development and manufacturing organization (CDMO) specializing in process development and small batch CGMP production of therapeutic antibodies, announced the closing of their Series A financing round.
read more
Berkshire Sterile Manufacturing (BSM), a fill finish CDMO located in Lee, MA, recently purchased a high precision load cell to perform non-destructive weight checks as part of their low loss fill process.
read more
Discovery Life Sciences™ has acquired Seattle-based ReachBio Research Labs (ReachBio®), a company specializing in cell-based assays, predictive hematotoxicity, and drug screening services.
read more
Rentschler Biopharma, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Thomas aus dem Siepen as Global Head Digital Manufacturing and Automation, effective April 1, 2023.
read more
The Contract Network, a startup collaboration platform focused on radically accelerating contract negotiations and simplifying contract compliance, has entered into a know-how agreement with Mayo Clinic to build a solution that will simplify the ...
read more
Wednesday, April 12, 2023
Meridian Medical Technologies, a Kindeva Drug Delivery Company, a global CDMO focused on drug-device combination products, announced it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next ...
read more
Sobi® announced a streamlining and simplification of the contractual economics for nirsevimab.
read more
Avid Bioservices announced the completion of two expansions within the company’s mammalian cell facilities. The company expects that the first customer for the newly expanded CGMP mammalian cell suites will begin manufacture this month.
read more
WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO) has added two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing at its Changzhou campus.
read more
Evergreen Discovery (Evergreen), a radiopharmaceutical drug development company with a focus on the treatment and diagnosis of cancer, and Orbit Discovery Ltd (Orbit), a provider of discovery services for therapeutic peptides, have entered into a ...
read more
Eckert & Ziegler and a subsidiary of POINT Biopharma Global Inc. have signed an agreement on the supply of Actinium-225 (non-carrier-added Ac-225). Eckert & Ziegler will provide predetermined amounts of GMP grade Ac-225 to POINT for use in the ...
read more
Cryoport, Inc. announced a multi-year agreement with Inception Fertility™. Inception Fertility operates The Prelude Network® (Prelude), a network of fertility centers in North America, and MyEggBank®, a network of donor egg banks and practices in ...
read more
Catawba Research, a full-service contract research organization (CRO) announced Andy Silverman, Ph.D., has joined its leadership team as its chief operating officer (COO).
read more
Wednesday, March 29, 2023
Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization (CDMO), announced the appointment of Gary Welch as Interim President.
read more